![](https://investorshub.advfn.com/uicon/65063.png?cb=1464334742)
Tuesday, March 07, 2023 10:14:03 AM
I am guessing there are QUITE a few shorts piling on this .. Are they defenseless ?
" I can't complain , but sometimes I still do . "
Recent PBLA News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/16/2024 09:25:03 PM
- Panbela Provides Business Update and Reports Q2 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 08:10:06 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/30/2024 09:30:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:59:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2024 08:46:53 PM
- Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification • GlobeNewswire Inc. • 06/24/2024 12:00:00 PM
- Panbela Announces Oral Presentation at Digestive Disease Week (DDW): • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:00:27 AM
- Panbela Provides Business Update and Reports Q1 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:10:39 PM
- Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024 • GlobeNewswire Inc. • 05/01/2024 08:15:00 PM
- Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/26/2024 08:39:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/25/2024 08:36:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:35:56 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 04/25/2024 01:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:02:00 PM
- Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/18/2024 08:31:22 PM
- Panbela Announces Poster Presentation at American Association for Cancer Research: • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2024 12:36:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/17/2024 04:15:36 AM
- Panbela Announces Transfer to OTCQB Market • GlobeNewswire Inc. • 04/16/2024 09:29:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/04/2024 08:17:05 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM